down arrow

Novartis India

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
788.00
6.05 (0.77%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 14.33 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: Novartis India will declare its result soon on 09 May 2025
stock-summaryPrice Point
High/Low

1Day

785.00796.95

52 Week

744.951,248.00
Valuation
Technical
Day's Volume

CASH

14.33 k (207.41%) Volume

Shareholding (Dec 2024)

FII

0.19%

Held by 18 FIIs

DII

0.53%

Held by 1 DIIs

Promoter

70.68%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Stock is technically in a Bearish range

  • The technical trend has deteriorated from Mildly Bearish on 25-Mar-25 and has generated -5.08% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
2

Despite the size of the company, domestic mutual funds hold only 0.01% of the company

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,957 Cr (Small Cap)

stock-summary
P/E

22.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

3.20%

stock-summary
Debt Equity

-0.81

stock-summary
Return on Equity

11.83%

stock-summary
Price to Book

2.65

Revenue and Profits (1 Year):
Net Sales:
93 Cr
(Quarterly Results - Dec 2024)
Net Profit:
25 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (3.2%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-23.92%
0%
-23.92%
1 Year
-24.53%
2.41%
-22.12%
2 Years
32.14%
5.86%
38.0%
3 Years
19.34%
7.78%
27.12%
4 Years
33.85%
8.61%
42.46%
5 Years
38.73%
11.70%
50.43%

Latest dividend: 25 per share ex-dividend date: Jul-23-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.92%
EBIT Growth (5y)
49.38%
EBIT to Interest (avg)
29.90
Debt to EBITDA (avg)
1.40
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.50
Tax Ratio
26.79%
Dividend Payout Ratio
72.43%
Pledged Shares
0
Institutional Holding
0.72%
ROCE (avg)
19.26%
ROE (avg)
8.75%
Valuation key factors
Factor
Value
P/E Ratio
22
Industry P/E
33
Price to Book Value
2.65
EV to EBIT
17.41
EV to EBITDA
17.01
EV to Capital Employed
9.70
EV to Sales
3.79
PEG Ratio
NA
Dividend Yield
3.20%
ROCE (Latest)
51.71%
ROE (Latest)
11.83%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 6 Schemes (0.0%)

FIIs

Held by 18 FIIs (0.19%)

Promoter with highest holding

Novartis Ag (70.68%)

Highest Public shareholder

Atul Limited (1.52%)

Individual Investors Holdings

23.01%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 10.01% vs 5.45% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -4.22% vs 249.15% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "93.00",
          "val2": "84.54",
          "chgp": "10.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25.58",
          "val2": "19.77",
          "chgp": "29.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "0.16",
          "chgp": "125.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "25.45",
          "val2": "26.57",
          "chgp": "-4.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.51%",
          "val2": "23.39%",
          "chgp": "4.12%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 5.92% vs -23.86% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 5.03% vs -37.88% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "179.39",
          "val2": "169.36",
          "chgp": "5.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "41.93",
          "val2": "34.28",
          "chgp": "22.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.29",
          "val2": "1.17",
          "chgp": "-75.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "46.15",
          "val2": "43.94",
          "chgp": "5.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.37%",
          "val2": "20.24%",
          "chgp": "3.13%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 7.28% vs -16.10% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 1.55% vs -9.99% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "272.39",
          "val2": "253.90",
          "chgp": "7.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "67.51",
          "val2": "54.05",
          "chgp": "24.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.65",
          "val2": "1.33",
          "chgp": "-51.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "71.60",
          "val2": "70.51",
          "chgp": "1.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.78%",
          "val2": "21.29%",
          "chgp": "3.49%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -11.53% vs -5.28% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -17.58% vs 2,878.49% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "335.07",
          "val2": "378.74",
          "chgp": "-11.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "65.26",
          "val2": "65.08",
          "chgp": "0.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.49",
          "val2": "1.75",
          "chgp": "-14.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "85.19",
          "val2": "103.36",
          "chgp": "-17.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.48%",
          "val2": "17.18%",
          "chgp": "2.30%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
93.00
84.54
10.01%
Operating Profit (PBDIT) excl Other Income
25.58
19.77
29.39%
Interest
0.36
0.16
125.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
25.45
26.57
-4.22%
Operating Profit Margin (Excl OI)
27.51%
23.39%
4.12%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 10.01% vs 5.45% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is -4.22% vs 249.15% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
179.39
169.36
5.92%
Operating Profit (PBDIT) excl Other Income
41.93
34.28
22.32%
Interest
0.29
1.17
-75.21%
Exceptional Items
0.00
0.00
Standalone Net Profit
46.15
43.94
5.03%
Operating Profit Margin (Excl OI)
23.37%
20.24%
3.13%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 5.92% vs -23.86% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 5.03% vs -37.88% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
272.39
253.90
7.28%
Operating Profit (PBDIT) excl Other Income
67.51
54.05
24.90%
Interest
0.65
1.33
-51.13%
Exceptional Items
0.00
0.00
Standalone Net Profit
71.60
70.51
1.55%
Operating Profit Margin (Excl OI)
24.78%
21.29%
3.49%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 7.28% vs -16.10% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 1.55% vs -9.99% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
335.07
378.74
-11.53%
Operating Profit (PBDIT) excl Other Income
65.26
65.08
0.28%
Interest
1.49
1.75
-14.86%
Exceptional Items
0.00
0.00
Standalone Net Profit
85.19
103.36
-17.58%
Operating Profit Margin (Excl OI)
19.48%
17.18%
2.30%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -11.53% vs -5.28% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -17.58% vs 2,878.49% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Novartis India Ltd stock-summary
stock-summary
Novartis India Ltd
Small Cap
Pharmaceuticals & Drugs
Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947. The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health.
Company Coordinates stock-summary
Company Details
The Inspire BKC Part 601 & 701, Bandra Kurla Complex Bandra(E) Mumbai Maharashtra : 400051
stock-summary
Tel: 91-022-50243000
stock-summary
http://www.novartis.in
stock-summary
india.investors@novartis.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."